Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3
about
Prospects for vaccine prevention of meningococcal infectionSerology, chemistry, and genetics of O and K antigens of Escherichia coliAge-related immunity to meningococcal serogroup C vaccination: an increase in the persistence of IgG2 correlates with a decrease in the avidity of IgGImmunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccineEscherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies.Heteroimmunization to the capsular polysaccharide of Haemophilus influenzae type b induced by enteric cross-reacting bacteria.Bacillus pumilus polysaccharide cross-reactive with meningococcal group A polysaccharide.Immunology of the infant rat experimental model of Haemophilus influenzae type b meningitisSignificance of noncapsular antigens in protection against experimental Haemophilus influenzae type b disease: cross-reactivityAssociation between cross-reacting Escherichia coli K100 and disease caused by Haemophilus influenzae type bPolysaccharides of the genus Bacillus cross-reactive with the capsular polysaccharides of Diplococcus pneumoniae type 3, Haemophilus influenzae type b, and Neisseria meningitidis group A.Meningococcal group C conjugate vaccines.Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants.Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera.A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis BeltStaphylococcus aureus and Streptococcus pneumoniae interaction and response to pneumococcal vaccination: Myth or reality?Duration of the immune response in subjects inoculated with antimeningococcal A and C vaccines kept in storage at -20 degrees C and at 4 degrees C: influence of pre-vaccination titres on the vaccinal responseMolecular cloning and analysis of genes for production of K5, K7, K12, and K92 capsular polysaccharides in Escherichia coli.Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years.Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac.Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era.Pneumococci in nasopharyngeal samples from Filipino children with acute respiratory infections.Antibodies to poly[(2----8)-alpha-N-acetylneuraminic acid] and poly[(2----9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1.Counterimmunoelectrophoresis in the diagnosis of bacterial meningitisPractical considerations in using counterimmunoelectrophoresis to identify the principal causative agents of bacterial meningitis.Determination of bacterial meningitis: a retrospective study of 80 cerebrospinal fluid specimens evaluated by four in vitro methods.Detection of Pneumococcal Capsular polysaccharide antigens by latex agglutination, counterimmunoelectrophoresis, and radioimmunoassay in middle ear exudates in acute otitis media.Immunoglobulin M and G antibody responses and persistence of these antibodies in adults after vaccination with a combined meningococcal group A and group C polysaccharide vaccine.Six widespread bacterial clones among Escherichia coli K1 isolates.Inhibition of Neisseria gonorrhoeae by a bacteriocin from Pseudomonas aeruginosa.Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37.Crossreactions of Escherichia coli K and O polysaccharides in antipneumococcal and anti-Salmonella sera.Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine.Immunogenicity of meningococcal ACYW135 polysaccharide vaccine in Saudi children 5 to 9 years of age.Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway.
P2860
Q24537338-34AB11AF-8AF0-4F4C-AA0A-65366C21F66CQ24564133-6EACD62D-748A-47A5-A90B-24DB569943A6Q28741100-1F0F25B1-A42B-46E3-9C5F-1AF8727CCAF2Q28749695-A4C46844-BE51-4F50-AD2F-8BB3F3BCEB6AQ30442755-4FDFF063-5505-4F4F-8502-49BBD867B258Q34120272-7826E602-89C6-41B1-BB1E-F4A826DC8560Q34397696-3AB5166E-07A6-4B85-AF2D-5C6E1AF1B80EQ34430393-873032F2-67FD-477A-8E75-738B4BA4A5C3Q34453364-7B6327B9-75FF-45E6-8091-2B5AB5E5FA58Q34459413-BB08BFC1-7917-4F90-8A3E-D5B52454498DQ34498786-4C02A440-D929-4379-AF48-827F69C2055FQ35269816-E072CE73-82A2-4256-9021-36C182C871B6Q35783511-5E148E40-42BE-4806-866C-C71DCF11F46DQ35901911-CAE99614-A2ED-4D15-8551-DF2CCB2BFA78Q35905135-14D892F8-6672-4ACE-8C00-14BE2BD48582Q35922578-F4E7FCE8-6B37-4EBF-B13D-4E89C691CDE3Q35932254-03D10DE8-4A56-42C5-BC79-C89DD443157AQ36257988-E1A3A3AD-EE70-4681-9FEE-23405F512144Q36262165-AD18FD98-BCE7-4D4A-920B-F647599C2722Q36265032-FE7BA6B2-1D64-47AA-9A1C-114EA64EACB2Q36265075-0766E674-401B-49D5-BC7D-226A2001EC3DQ36974336-A7E03CB1-9DCD-43A6-ACEF-A7D2B7BA1D55Q37095945-912F24C7-DFB6-47A1-820B-F710593D1952Q37579118-F84DB636-EFB7-40EE-B822-13453ACBAB78Q39432230-25C98810-2BDF-4E78-A478-D7DAF3FE0A6FQ39585118-7FFB18CD-83DD-45F1-992B-A73F4B800B09Q40224846-F61AF6D3-4F53-436C-984A-614E56ADD5EFQ40229733-F1B566EA-69C0-433B-9E72-BD63543DDE11Q40598152-85A2C699-9EB2-4971-9A73-98A6145DDB95Q40599761-5C36BDDD-9111-4561-BE46-BD309EC9036AQ40947154-8B4B934B-286E-4710-AF1C-1006A0B334F0Q41825787-B5B2379F-099B-4E48-9239-427D6E5E77F0Q41827106-7EFF3577-B24B-47D9-987B-A0C0F0D9D5D9Q41857495-20C3C7D9-97EC-42B2-980A-8397A696874FQ42082720-CF326292-DBBC-40FA-B46B-33889B6D7B0DQ42940715-4B1128C4-B455-4446-A030-BE0EFC51787A
P2860
Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3
description
1972 nî lūn-bûn
@nan
1972 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1972 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1972年の論文
@ja
1972年論文
@yue
1972年論文
@zh-hant
1972年論文
@zh-hk
1972年論文
@zh-mo
1972年論文
@zh-tw
1972年论文
@wuu
name
Enteric bacteria cross-reactiv ...... occus pneumoniae types I and 3
@ast
Enteric bacteria cross-reactiv ...... occus pneumoniae types I and 3
@en
Enteric bacteria cross-reactiv ...... occus pneumoniae types I and 3
@nl
type
label
Enteric bacteria cross-reactiv ...... occus pneumoniae types I and 3
@ast
Enteric bacteria cross-reactiv ...... occus pneumoniae types I and 3
@en
Enteric bacteria cross-reactiv ...... occus pneumoniae types I and 3
@nl
prefLabel
Enteric bacteria cross-reactiv ...... occus pneumoniae types I and 3
@ast
Enteric bacteria cross-reactiv ...... occus pneumoniae types I and 3
@en
Enteric bacteria cross-reactiv ...... occus pneumoniae types I and 3
@nl
P2093
P2860
P1476
Enteric bacteria cross-reactiv ...... occus pneumoniae types I and 3
@en
P2093
Gotschlich EC
Handzel ZT
Myerowitz L
Robbins JB
Schneerson R
Whisnant JK
P2860
P304
P407
P577
1972-11-01T00:00:00Z